Gabapentin vs. Pregabalin for Nerve Pain After an Accident

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | May 14, 2024 | 8 min read

Gabapentin and pregabalin (Lyrica) are both gabapentinoids used for neuropathic pain from herniated discs, radiculopathy, and nerve injuries after accidents. They work the same way — but their pharmacokinetics differ significantly, and that difference matters for consistent pain control in personal injury patients.

Gabapentin vs. Pregabalin for Nerve Pain After an Accident

Personal injury accidents frequently damage nerve roots, peripheral nerves, or create disc herniations that compress nerves. The resulting neuropathic pain — burning, shooting, electric, or radiating — does not respond well to standard analgesics. Gabapentinoids are the first-line drug class for this type of pain.

Two drugs dominate this space: gabapentin (generic, and Neurontin) and pregabalin (Lyrica, now also generic). A third option, gabapentin enacarbil (Horizant), addresses a key limitation of immediate-release gabapentin. Understanding the differences helps attorneys interpret prescribing decisions — and helps clinicians select the right agent for each patient.

[!KEY] Gabapentin and pregabalin target the same calcium channel receptor and treat the same neuropathic pain conditions, but pregabalin's linear absorption produces more consistent blood levels, more predictable pain control, and twice-daily dosing — while its Schedule V status creates additional clinical documentation that can support injury severity arguments.

Mechanism: Same Target, Different Delivery

Both gabapentin and pregabalin bind to the alpha-2-delta (α2δ) subunit of voltage-gated calcium channels in the dorsal horn of the spinal cord — the relay station for pain signals from the body to the brain. This binding reduces the release of excitatory neurotransmitters (glutamate, substance P, norepinephrine), calming hyperactive pain signaling.

The mechanism is identical. The difference is in how each drug gets into the bloodstream.

The Absorption Difference: This Is What Actually Matters

Gabapentin (immediate-release) is absorbed in the upper small intestine through a transporter called LAT1 — a saturable transporter. As dose increases, the transporter becomes saturated, and absorption becomes non-linear. This means:

• At low doses: absorbed predictably
• At higher doses: the percentage absorbed drops significantly
• Blood levels are variable and unpredictable
• Patients may need 3x daily dosing to maintain therapeutic levels throughout the day
• Increasing the dose beyond a certain point produces diminishing returns

Pregabalin is absorbed through the same transporter system but with higher affinity and capacity, producing linear, dose-proportional pharmacokinetics. What this means practically:

• Doubling the dose reliably doubles the blood level
• Blood levels are consistent and predictable
• Twice-daily dosing is sufficient
• More consistent pain control throughout the day

*Note: Some states have scheduled gabapentin. Check state-specific scheduling.

Why Would a Physician Choose Pregabalin Over Gabapentin?

For a PI patient with neuropathic pain, the prescribing decision depends on the clinical picture:

Choose pregabalin when:

• Consistent therapeutic blood levels are important — the patient has unpredictable nerve pain that needs steady drug coverage
• The patient has previously failed gabapentin due to variable response
• Twice-daily dosing is preferred over three times daily (adherence advantage)
• The patient has spinal cord injury-related pain (pregabalin has an FDA indication here; gabapentin does not)
• Clinical evidence in fibromyalgia is needed (pregabalin is FDA-approved; gabapentin is not)

Choose gabapentin when:

• The patient's insurance covers gabapentin or prior authorization is already in place for it
• The patient has lower nerve pain severity and lower doses will be used (the absorption limitations are less clinically significant at lower doses)
• The patient has insurance that prefers gabapentin first

Pregabalin as a Controlled Substance: The PI Documentation Angle

Pregabalin is Schedule V — the same scheduling as certain cough preparations with low codeine content. While Schedule V is the mildest controlled substance classification, it creates specific documentation:

• DEA scheduling appears in prescribing records
• The prescriber must make a deliberate clinical decision to prescribe a controlled substance
• This documentation can support injury severity arguments — the treating physician determined the patient's neuropathic pain was severe enough to warrant a Schedule V controlled substance

Gabapentin (at the federal level) does not carry this documentation weight. A physician who prescribes pregabalin — a controlled substance — is implicitly documenting that gabapentin was either insufficient or the clinical picture warranted the more potent option.

Horizant (Gabapentin Enacarbil): The Bridge Between the Two

Gabapentin enacarbil (Horizant) was developed specifically to solve the absorption problem of immediate-release gabapentin. It uses a completely different absorption transporter (SMVT — sodium-dependent multivitamin transporter) that is non-saturable and distributed throughout the intestine rather than only in the upper small bowel.

The result: gabapentin enacarbil provides the linear, predictable pharmacokinetics of pregabalin — without the Schedule V controlled substance classification of pregabalin.

[!KEY] A prescription for Horizant (gabapentin enacarbil) signals that the physician specifically selected a formulation engineered to solve gabapentin's absorption variability — this prescribing decision documents that immediate-release gabapentin was clinically inadequate and the patient's nerve pain required a more pharmacokinetically reliable agent.

For PI patients who need:

• Consistent blood levels (like pregabalin)
• Once-daily dosing
• No controlled substance documentation

Horizant represents the clinically optimal choice — combining the non-controlled status of gabapentin with the pharmacokinetic superiority of pregabalin.

Side Effect Comparison

All gabapentinoids share a class-effect side effect profile, but there are differences:

The smoother absorption profile of pregabalin and Horizant tends to produce less variable side effects than the peaks and troughs of immediate-release gabapentin.

Interpreting the Prescribing Choice for Attorneys

[!TIP] When reviewing a client's medication history, an escalation from gabapentin to pregabalin — or a direct prescription of Horizant — is explicit documentation that initial neuropathic therapy was insufficient and the physician stepped up to a more reliable agent, strengthening nerve-involvement arguments in the demand.

When a treating physician selects pregabalin or Horizant over generic gabapentin, this reflects:

1. Clinical significance of neuropathic pain — the prescriber determined that the patient needed the more pharmacokinetically reliable agent
2. Deliberate prescribing — choosing a specific medication over the cheapest available option reflects physician judgment about the patient's clinical needs
3. Controlled substance (pregabalin) — a Schedule V prescription documents physician determination that prescription-class neuropathic pain management was warranted

When a physician escalates from gabapentin to pregabalin — as documented in a medication history — this represents explicit documentation that initial gabapentin therapy was insufficient and the patient's neuropathic pain required stepping up to a more potent, more reliable agent.

Common PI Nerve Pain Scenarios

Cervical radiculopathy from herniated C5-6: Typically presents as shooting pain down the arm, numbness in specific fingers. Gabapentinoids are first-line; pregabalin or Horizant for consistent coverage during recovery.

Lumbar radiculopathy (sciatica): Classic shooting leg pain from L4-5 or L5-S1 disc herniation. Gabapentinoids address the neuropathic component; NSAIDs or steroids address the inflammatory component. Often used together.

Thoracic nerve injury from T-bone impact: Direct rib/thoracic trauma can injure intercostal nerves, producing chronic chest-wall neuropathic pain. Gabapentinoids are appropriate.

Peripheral nerve injury at the impact site: Direct trauma can damage peripheral nerves, producing chronic neuropathic pain at the injury site. Gabapentinoids, SNRIs, and topical agents (ZTlido, lidocaine patches) are used in combination.

[!KEY] When a client's pharmacy record shows gabapentin, pregabalin, and a topical agent like ZTlido all prescribed simultaneously for the same injury site, the combination documents multi-mechanism neuropathic pain that has resisted single-agent control — a pattern that directly supports both injury severity and the medical necessity of each individual medication.

[!SOURCE] FDA prescribing information for gabapentin and pregabalin — FDA-approved indications and prescribing information.

LienScripts covers gabapentin, pregabalin, and Horizant for personal injury patients at $0 upfront cost. Contact LienScripts to discuss pharmacy lien coverage.

Related Resources

• Gabapentin for Whiplash and Cervical Nerve Pain
• Pregabalin for Nerve Damage After a Car Accident
• Non-Opioid Pain Management in Personal Injury Cases: 2025 Update
• Gabapentin for Personal Injury Cases: Attorney's Guide — Clinical guide to gabapentin's role in PI cases and how it supports medical necessity